nodes	percent_of_prediction	percent_of_DWPC	metapath
Podofilox—CYP2C19—Cholecalciferol—osteoporosis	0.0686	0.143	CbGbCtD
Podofilox—CYP3A4—Estropipate—osteoporosis	0.0644	0.134	CbGbCtD
Podofilox—CYP3A4—Calcitriol—osteoporosis	0.0644	0.134	CbGbCtD
Podofilox—CYP2C19—Estradiol—osteoporosis	0.0553	0.115	CbGbCtD
Podofilox—CYP3A4—Ergocalciferol—osteoporosis	0.0515	0.107	CbGbCtD
Podofilox—CYP3A4—Raloxifene—osteoporosis	0.043	0.0897	CbGbCtD
Podofilox—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0415	0.0866	CbGbCtD
Podofilox—CYP3A4—Cholecalciferol—osteoporosis	0.0332	0.0692	CbGbCtD
Podofilox—CYP3A4—Conjugated Estrogens—osteoporosis	0.0305	0.0636	CbGbCtD
Podofilox—CYP3A4—Estradiol—osteoporosis	0.0267	0.0558	CbGbCtD
Podofilox—TUBA4A—Formation of tubulin folding intermediates by CCT/TriC—CCT2—osteoporosis	0.0127	0.0551	CbGpPWpGaD
Podofilox—Skin burning sensation—Calcitriol—osteoporosis	0.0124	0.0439	CcSEcCtD
Podofilox—TUBA4A—Post-chaperonin tubulin folding pathway—TUBA1B—osteoporosis	0.0117	0.0507	CbGpPWpGaD
Podofilox—TUBA4A—Formation of tubulin folding intermediates by CCT/TriC—TUBA1B—osteoporosis	0.0108	0.0468	CbGpPWpGaD
Podofilox—TUBA4A—Prefoldin mediated transfer of substrate to CCT/TriC—CCT2—osteoporosis	0.0104	0.045	CbGpPWpGaD
Podofilox—TUBA4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—CCT2—osteoporosis	0.0101	0.0437	CbGpPWpGaD
Podofilox—TUBA4A—Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding—TUBA1B—osteoporosis	0.0086	0.0372	CbGpPWpGaD
Podofilox—Tingling sensation—Calcium Acetate—osteoporosis	0.00709	0.025	CcSEcCtD
Podofilox—Stinging—Calcium Acetate—osteoporosis	0.00704	0.0248	CcSEcCtD
Podofilox—TUBA4A—Chaperonin-mediated protein folding—CCT2—osteoporosis	0.00647	0.028	CbGpPWpGaD
Podofilox—Localized exfoliation—Estradiol—osteoporosis	0.00636	0.0224	CcSEcCtD
Podofilox—Application site irritation—Estradiol—osteoporosis	0.00617	0.0217	CcSEcCtD
Podofilox—TUBA4A—Protein folding—CCT2—osteoporosis	0.0059	0.0255	CbGpPWpGaD
Podofilox—TUBA4A—Chaperonin-mediated protein folding—TUBA1B—osteoporosis	0.0055	0.0238	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—WDR1—osteoporosis	0.00527	0.0228	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.00502	0.0217	CbGpPWpGaD
Podofilox—TUBA4A—Protein folding—TUBA1B—osteoporosis	0.00501	0.0217	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00501	0.0217	CbGpPWpGaD
Podofilox—Redness—Ibandronate—osteoporosis	0.0046	0.0162	CcSEcCtD
Podofilox—Redness—Calcitriol—osteoporosis	0.0045	0.0159	CcSEcCtD
Podofilox—Blister—Estropipate—osteoporosis	0.00449	0.0158	CcSEcCtD
Podofilox—TUBB—Pathogenic Escherichia coli infection—TUBA1B—osteoporosis	0.00426	0.0184	CbGpPWpGaD
Podofilox—Blister—Calcitriol—osteoporosis	0.00422	0.0149	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—CAP1—osteoporosis	0.00417	0.018	CbGpPWpGaD
Podofilox—TUBA4A—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00413	0.0179	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.00397	0.0172	CbGpPWpGaD
Podofilox—Tenderness—Estropipate—osteoporosis	0.00371	0.0131	CcSEcCtD
Podofilox—Redness—Pamidronate—osteoporosis	0.0036	0.0127	CcSEcCtD
Podofilox—Tenderness—Raloxifene—osteoporosis	0.00359	0.0127	CcSEcCtD
Podofilox—TUBB—Parkin-Ubiquitin Proteasomal System pathway—TUBA1B—osteoporosis	0.00351	0.0152	CbGpPWpGaD
Podofilox—TUBA4A—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00347	0.015	CbGpPWpGaD
Podofilox—Ulcer—Alendronate—osteoporosis	0.00337	0.0119	CcSEcCtD
Podofilox—Inflammation—Estropipate—osteoporosis	0.00334	0.0118	CcSEcCtD
Podofilox—Redness—Zoledronate—osteoporosis	0.00329	0.0116	CcSEcCtD
Podofilox—Ulcer—Ibandronate—osteoporosis	0.00328	0.0116	CcSEcCtD
Podofilox—Inflammation—Ibandronate—osteoporosis	0.0032	0.0113	CcSEcCtD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.00317	0.0137	CbGpPWpGaD
Podofilox—Haematuria—Calcium Acetate—osteoporosis	0.00304	0.0107	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—PLEK—osteoporosis	0.00303	0.0131	CbGpPWpGaD
Podofilox—Blister—Conjugated Estrogens—osteoporosis	0.00297	0.0105	CcSEcCtD
Podofilox—TUBB—Pathogenic Escherichia coli infection—ACTG1—osteoporosis	0.00295	0.0128	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.00288	0.0125	CbGpPWpGaD
Podofilox—Ulcer—Risedronate—osteoporosis	0.00271	0.00954	CcSEcCtD
Podofilox—Tingling sensation—Conjugated Estrogens—osteoporosis	0.00266	0.00938	CcSEcCtD
Podofilox—Inflammation—Risedronate—osteoporosis	0.00264	0.0093	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—TLN1—osteoporosis	0.00261	0.0113	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—VCL—osteoporosis	0.00257	0.0111	CbGpPWpGaD
Podofilox—Swelling—Ibandronate—osteoporosis	0.00255	0.00901	CcSEcCtD
Podofilox—Redness—Estradiol—osteoporosis	0.00254	0.00894	CcSEcCtD
Podofilox—Inflammation—Pamidronate—osteoporosis	0.00251	0.00884	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.00249	0.0107	CbGpPWpGaD
Podofilox—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.00248	0.0107	CbGpPWpGaD
Podofilox—Dermatitis bullous—Estropipate—osteoporosis	0.00246	0.00867	CcSEcCtD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.00246	0.0106	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.00245	0.0106	CbGpPWpGaD
Podofilox—Tenderness—Conjugated Estrogens—osteoporosis	0.00245	0.00864	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.00234	0.0101	CbGpPWpGaD
Podofilox—Dermatitis bullous—Calcitriol—osteoporosis	0.00231	0.00814	CcSEcCtD
Podofilox—Inflammation—Zoledronate—osteoporosis	0.00229	0.00808	CcSEcCtD
Podofilox—Ulcer—Conjugated Estrogens—osteoporosis	0.00226	0.00797	CcSEcCtD
Podofilox—Inflammation—Conjugated Estrogens—osteoporosis	0.00221	0.00778	CcSEcCtD
Podofilox—Skin ulcer—Estradiol—osteoporosis	0.0022	0.00775	CcSEcCtD
Podofilox—TOP2A—Circadian rythm related genes—ID4—osteoporosis	0.00216	0.00936	CbGpPWpGaD
Podofilox—Dry skin—Alendronate—osteoporosis	0.00212	0.00748	CcSEcCtD
Podofilox—Oedema—Calcium Acetate—osteoporosis	0.00203	0.00717	CcSEcCtD
Podofilox—Swelling—Pamidronate—osteoporosis	0.002	0.00706	CcSEcCtD
Podofilox—TOP2A—Fulvestrant—Estradiol—osteoporosis	0.00199	0.337	CbGdCrCtD
Podofilox—Tenderness—Estradiol—osteoporosis	0.00196	0.00692	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—FGA—osteoporosis	0.00195	0.00843	CbGpPWpGaD
Podofilox—Skin discolouration—Estradiol—osteoporosis	0.0019	0.00668	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.00186	0.00804	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.00185	0.00799	CbGpPWpGaD
Podofilox—Swelling—Zoledronate—osteoporosis	0.00183	0.00645	CcSEcCtD
Podofilox—Paraesthesia—Calcium Acetate—osteoporosis	0.00183	0.00644	CcSEcCtD
Podofilox—Ulcer—Estradiol—osteoporosis	0.00181	0.00638	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—FGB—osteoporosis	0.00178	0.00767	CbGpPWpGaD
Podofilox—Inflammation—Estradiol—osteoporosis	0.00177	0.00622	CcSEcCtD
Podofilox—Swelling—Conjugated Estrogens—osteoporosis	0.00176	0.00621	CcSEcCtD
Podofilox—Pain—Calcium Acetate—osteoporosis	0.00174	0.00613	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.00169	0.00731	CbGpPWpGaD
Podofilox—Erythema—Etidronic acid—osteoporosis	0.00164	0.00577	CcSEcCtD
Podofilox—Skin exfoliation—Estradiol—osteoporosis	0.00163	0.00576	CcSEcCtD
Podofilox—Dermatitis bullous—Conjugated Estrogens—osteoporosis	0.00162	0.00573	CcSEcCtD
Podofilox—Haemoglobin—Alendronate—osteoporosis	0.00161	0.00567	CcSEcCtD
Podofilox—Haemorrhage—Alendronate—osteoporosis	0.0016	0.00565	CcSEcCtD
Podofilox—Haemoglobin—Ibandronate—osteoporosis	0.00157	0.00552	CcSEcCtD
Podofilox—Haemorrhage—Ibandronate—osteoporosis	0.00156	0.0055	CcSEcCtD
Podofilox—Pain—Ergocalciferol—osteoporosis	0.00154	0.00542	CcSEcCtD
Podofilox—Haemoglobin—Calcitriol—osteoporosis	0.00153	0.00541	CcSEcCtD
Podofilox—Haemorrhage—Calcitriol—osteoporosis	0.00153	0.00538	CcSEcCtD
Podofilox—Immune system disorder—Estropipate—osteoporosis	0.00147	0.00518	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.00147	0.00635	CbGpPWpGaD
Podofilox—Pruritus—Calcium Acetate—osteoporosis	0.00144	0.00507	CcSEcCtD
Podofilox—Erythema—Estropipate—osteoporosis	0.00142	0.00499	CcSEcCtD
Podofilox—Swelling—Estradiol—osteoporosis	0.00141	0.00497	CcSEcCtD
Podofilox—Immune system disorder—Ibandronate—osteoporosis	0.00141	0.00497	CcSEcCtD
Podofilox—Erythema—Alendronate—osteoporosis	0.00139	0.00491	CcSEcCtD
Podofilox—Erythema—Ibandronate—osteoporosis	0.00136	0.00479	CcSEcCtD
Podofilox—Dizziness—Calcium Acetate—osteoporosis	0.00135	0.00474	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.00134	0.00581	CbGpPWpGaD
Podofilox—Erythema—Calcitriol—osteoporosis	0.00133	0.00468	CcSEcCtD
Podofilox—Haemoglobin—Ethinyl Estradiol—osteoporosis	0.00132	0.00467	CcSEcCtD
Podofilox—Haemorrhage—Ethinyl Estradiol—osteoporosis	0.00132	0.00465	CcSEcCtD
Podofilox—TOP2A—Levorphanol—Estradiol—osteoporosis	0.00132	0.222	CbGdCrCtD
Podofilox—Haematuria—Pamidronate—osteoporosis	0.0013	0.00457	CcSEcCtD
Podofilox—Vomiting—Calcium Acetate—osteoporosis	0.00129	0.00456	CcSEcCtD
Podofilox—Haemoglobin—Risedronate—osteoporosis	0.00129	0.00455	CcSEcCtD
Podofilox—Haemorrhage—Risedronate—osteoporosis	0.00128	0.00453	CcSEcCtD
Podofilox—Haemoglobin—Pamidronate—osteoporosis	0.00123	0.00433	CcSEcCtD
Podofilox—Haemorrhage—Pamidronate—osteoporosis	0.00122	0.00431	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—WDR1—osteoporosis	0.00121	0.00521	CbGpPWpGaD
Podofilox—TOP2A—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0012	0.203	CbGdCrCtD
Podofilox—Paraesthesia—Etidronic acid—osteoporosis	0.0012	0.00423	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.0012	0.00422	CcSEcCtD
Podofilox—Immune system disorder—Ethinyl Estradiol—osteoporosis	0.00119	0.0042	CcSEcCtD
Podofilox—Haematuria—Zoledronate—osteoporosis	0.00119	0.00418	CcSEcCtD
Podofilox—Immune system disorder—Risedronate—osteoporosis	0.00116	0.00409	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.00116	0.00409	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.00116	0.005	CbGpPWpGaD
Podofilox—Oedema—Estropipate—osteoporosis	0.00116	0.00407	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.00115	0.00405	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.00114	0.00494	CbGpPWpGaD
Podofilox—Dry skin—Estradiol—osteoporosis	0.00114	0.00402	CcSEcCtD
Podofilox—Skin disorder—Estropipate—osteoporosis	0.00112	0.00396	CcSEcCtD
Podofilox—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—VDR—osteoporosis	0.00111	0.00478	CbGpPWpGaD
Podofilox—Immune system disorder—Pamidronate—osteoporosis	0.0011	0.00389	CcSEcCtD
Podofilox—Skin disorder—Raloxifene—osteoporosis	0.00109	0.00383	CcSEcCtD
Podofilox—Skin disorder—Ibandronate—osteoporosis	0.00108	0.00379	CcSEcCtD
Podofilox—Erythema—Pamidronate—osteoporosis	0.00106	0.00375	CcSEcCtD
Podofilox—Skin disorder—Calcitriol—osteoporosis	0.00105	0.00371	CcSEcCtD
Podofilox—Insomnia—Estropipate—osteoporosis	0.00104	0.00368	CcSEcCtD
Podofilox—Paraesthesia—Estropipate—osteoporosis	0.00104	0.00366	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.00102	0.0044	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.00101	0.00438	CbGpPWpGaD
Podofilox—Insomnia—Raloxifene—osteoporosis	0.00101	0.00357	CcSEcCtD
Podofilox—Immune system disorder—Zoledronate—osteoporosis	0.00101	0.00355	CcSEcCtD
Podofilox—Insomnia—Ibandronate—osteoporosis	0.001	0.00353	CcSEcCtD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000996	0.0043	CbGpPWpGaD
Podofilox—Paraesthesia—Ibandronate—osteoporosis	0.000995	0.00351	CcSEcCtD
Podofilox—Pain—Estropipate—osteoporosis	0.000988	0.00348	CcSEcCtD
Podofilox—Insomnia—Calcitriol—osteoporosis	0.000981	0.00346	CcSEcCtD
Podofilox—Pain—Alendronate—osteoporosis	0.000973	0.00343	CcSEcCtD
Podofilox—Erythema—Zoledronate—osteoporosis	0.000971	0.00342	CcSEcCtD
Podofilox—Immune system disorder—Conjugated Estrogens—osteoporosis	0.00097	0.00342	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.00097	0.00342	CcSEcCtD
Podofilox—Pain—Raloxifene—osteoporosis	0.000957	0.00337	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000954	0.00413	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—CAP1—osteoporosis	0.000953	0.00412	CbGpPWpGaD
Podofilox—Pain—Ibandronate—osteoporosis	0.000947	0.00334	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000946	0.00333	CcSEcCtD
Podofilox—Pruritus—Etidronic acid—osteoporosis	0.000945	0.00333	CcSEcCtD
Podofilox—Oedema—Ethinyl Estradiol—osteoporosis	0.000936	0.0033	CcSEcCtD
Podofilox—Erythema—Conjugated Estrogens—osteoporosis	0.000935	0.0033	CcSEcCtD
Podofilox—Pain—Calcitriol—osteoporosis	0.000927	0.00327	CcSEcCtD
Podofilox—Haematuria—Estradiol—osteoporosis	0.000913	0.00322	CcSEcCtD
Podofilox—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000909	0.00321	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	0.000896	0.00387	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	0.000888	0.00384	CbGpPWpGaD
Podofilox—Skin disorder—Risedronate—osteoporosis	0.000887	0.00313	CcSEcCtD
Podofilox—Oedema—Pamidronate—osteoporosis	0.000868	0.00306	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000866	0.00374	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	0.000864	0.00374	CbGpPWpGaD
Podofilox—Haemoglobin—Estradiol—osteoporosis	0.000864	0.00305	CcSEcCtD
Podofilox—Haemorrhage—Estradiol—osteoporosis	0.00086	0.00303	CcSEcCtD
Podofilox—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	0.000851	0.00368	CbGpPWpGaD
Podofilox—Vomiting—Etidronic acid—osteoporosis	0.000849	0.00299	CcSEcCtD
Podofilox—Rash—Etidronic acid—osteoporosis	0.000842	0.00297	CcSEcCtD
Podofilox—Dermatitis—Etidronic acid—osteoporosis	0.000841	0.00297	CcSEcCtD
Podofilox—Headache—Etidronic acid—osteoporosis	0.000837	0.00295	CcSEcCtD
Podofilox—Insomnia—Risedronate—osteoporosis	0.000826	0.00291	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000821	0.0029	CcSEcCtD
Podofilox—Paraesthesia—Risedronate—osteoporosis	0.00082	0.00289	CcSEcCtD
Podofilox—Pruritus—Estropipate—osteoporosis	0.000817	0.00288	CcSEcCtD
Podofilox—Pruritus—Alendronate—osteoporosis	0.000805	0.00284	CcSEcCtD
Podofilox—TUBA4A—Platelet degranulation—IGF1—osteoporosis	0.000804	0.00347	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptors—VDR—osteoporosis	0.000804	0.00347	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	0.0008	0.00346	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	0.000797	0.00345	CbGpPWpGaD
Podofilox—Oedema—Zoledronate—osteoporosis	0.000793	0.00279	CcSEcCtD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000791	0.00279	CcSEcCtD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000787	0.0034	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—CCT2—osteoporosis	0.000786	0.0034	CbGpPWpGaD
Podofilox—Insomnia—Pamidronate—osteoporosis	0.000785	0.00277	CcSEcCtD
Podofilox—Pruritus—Ibandronate—osteoporosis	0.000784	0.00276	CcSEcCtD
Podofilox—TOP2A—Norethindrone—Ethinyl Estradiol—osteoporosis	0.000783	0.132	CbGdCrCtD
Podofilox—Pain—Risedronate—osteoporosis	0.000781	0.00275	CcSEcCtD
Podofilox—Paraesthesia—Pamidronate—osteoporosis	0.000779	0.00275	CcSEcCtD
Podofilox—Immune system disorder—Estradiol—osteoporosis	0.000777	0.00274	CcSEcCtD
Podofilox—Skin disorder—Zoledronate—osteoporosis	0.00077	0.00271	CcSEcCtD
Podofilox—Pruritus—Calcitriol—osteoporosis	0.000767	0.0027	CcSEcCtD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000766	0.00331	CbGpPWpGaD
Podofilox—Dizziness—Estropipate—osteoporosis	0.000764	0.00269	CcSEcCtD
Podofilox—Oedema—Conjugated Estrogens—osteoporosis	0.000763	0.00269	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—MGLL—osteoporosis	0.000757	0.00327	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	0.000753	0.00326	CbGpPWpGaD
Podofilox—Dizziness—Alendronate—osteoporosis	0.000752	0.00265	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	0.00075	0.00324	CbGpPWpGaD
Podofilox—Erythema—Estradiol—osteoporosis	0.000749	0.00264	CcSEcCtD
Podofilox—Pain—Pamidronate—osteoporosis	0.000742	0.00262	CcSEcCtD
Podofilox—Skin disorder—Conjugated Estrogens—osteoporosis	0.000741	0.00261	CcSEcCtD
Podofilox—Dizziness—Raloxifene—osteoporosis	0.00074	0.00261	CcSEcCtD
Podofilox—Vomiting—Estropipate—osteoporosis	0.000734	0.00259	CcSEcCtD
Podofilox—Dizziness—Ibandronate—osteoporosis	0.000733	0.00258	CcSEcCtD
Podofilox—Rash—Estropipate—osteoporosis	0.000728	0.00257	CcSEcCtD
Podofilox—Dermatitis—Estropipate—osteoporosis	0.000728	0.00257	CcSEcCtD
Podofilox—Headache—Estropipate—osteoporosis	0.000724	0.00255	CcSEcCtD
Podofilox—Vomiting—Alendronate—osteoporosis	0.000723	0.00255	CcSEcCtD
Podofilox—Rash—Alendronate—osteoporosis	0.000717	0.00253	CcSEcCtD
Podofilox—Insomnia—Zoledronate—osteoporosis	0.000717	0.00253	CcSEcCtD
Podofilox—Dermatitis—Alendronate—osteoporosis	0.000717	0.00253	CcSEcCtD
Podofilox—Headache—Alendronate—osteoporosis	0.000713	0.00251	CcSEcCtD
Podofilox—Paraesthesia—Zoledronate—osteoporosis	0.000712	0.00251	CcSEcCtD
Podofilox—Vomiting—Raloxifene—osteoporosis	0.000711	0.00251	CcSEcCtD
Podofilox—Rash—Raloxifene—osteoporosis	0.000706	0.00249	CcSEcCtD
Podofilox—Dermatitis—Raloxifene—osteoporosis	0.000705	0.00249	CcSEcCtD
Podofilox—Vomiting—Ibandronate—osteoporosis	0.000704	0.00248	CcSEcCtD
Podofilox—Headache—Raloxifene—osteoporosis	0.000701	0.00247	CcSEcCtD
Podofilox—Rash—Ibandronate—osteoporosis	0.000698	0.00246	CcSEcCtD
Podofilox—Dermatitis—Ibandronate—osteoporosis	0.000698	0.00246	CcSEcCtD
Podofilox—Headache—Ibandronate—osteoporosis	0.000694	0.00245	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—PLEK—osteoporosis	0.000692	0.00299	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—ANXA2—osteoporosis	0.000692	0.00299	CbGpPWpGaD
Podofilox—Insomnia—Conjugated Estrogens—osteoporosis	0.00069	0.00243	CcSEcCtD
Podofilox—Vomiting—Calcitriol—osteoporosis	0.000689	0.00243	CcSEcCtD
Podofilox—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000685	0.00242	CcSEcCtD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	0.000684	0.00296	CbGpPWpGaD
Podofilox—Rash—Calcitriol—osteoporosis	0.000684	0.00241	CcSEcCtD
Podofilox—Dermatitis—Calcitriol—osteoporosis	0.000683	0.00241	CcSEcCtD
Podofilox—Headache—Calcitriol—osteoporosis	0.000679	0.00239	CcSEcCtD
Podofilox—Pain—Zoledronate—osteoporosis	0.000678	0.00239	CcSEcCtD
Podofilox—TOP2A—Mitotic G1-G1/S phases—PSMA5—osteoporosis	0.000671	0.0029	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—PSMA2—osteoporosis	0.000671	0.0029	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000668	0.00289	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—TUBA1B—osteoporosis	0.000668	0.00289	CbGpPWpGaD
Podofilox—Pruritus—Ethinyl Estradiol—osteoporosis	0.000662	0.00234	CcSEcCtD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.00066	0.00285	CbGpPWpGaD
Podofilox—Pain—Conjugated Estrogens—osteoporosis	0.000653	0.0023	CcSEcCtD
Podofilox—Pruritus—Risedronate—osteoporosis	0.000646	0.00228	CcSEcCtD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000638	0.00276	CbGpPWpGaD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	0.000635	0.00274	CbGpPWpGaD
Podofilox—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000633	0.00223	CcSEcCtD
Podofilox—TOP2A—Levonorgestrel—Ethinyl Estradiol—osteoporosis	0.000623	0.105	CbGdCrCtD
Podofilox—Dizziness—Ethinyl Estradiol—osteoporosis	0.000619	0.00218	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptors—ESR1—osteoporosis	0.000614	0.00265	CbGpPWpGaD
Podofilox—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	0.000614	0.00265	CbGpPWpGaD
Podofilox—Pruritus—Pamidronate—osteoporosis	0.000614	0.00216	CcSEcCtD
Podofilox—TOP2A—Gastric Cancer Network 2—MYC—osteoporosis	0.000613	0.00265	CbGpPWpGaD
Podofilox—Oedema—Estradiol—osteoporosis	0.000611	0.00215	CcSEcCtD
Podofilox—Dizziness—Risedronate—osteoporosis	0.000604	0.00213	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—TLN1—osteoporosis	0.000597	0.00258	CbGpPWpGaD
Podofilox—Vomiting—Ethinyl Estradiol—osteoporosis	0.000595	0.0021	CcSEcCtD
Podofilox—Skin disorder—Estradiol—osteoporosis	0.000593	0.00209	CcSEcCtD
Podofilox—Rash—Ethinyl Estradiol—osteoporosis	0.00059	0.00208	CcSEcCtD
Podofilox—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00059	0.00208	CcSEcCtD
Podofilox—TUBA4A—Hemostasis—VCL—osteoporosis	0.000589	0.00254	CbGpPWpGaD
Podofilox—Headache—Ethinyl Estradiol—osteoporosis	0.000587	0.00207	CcSEcCtD
Podofilox—Vomiting—Risedronate—osteoporosis	0.00058	0.00205	CcSEcCtD
Podofilox—Rash—Risedronate—osteoporosis	0.000576	0.00203	CcSEcCtD
Podofilox—Dermatitis—Risedronate—osteoporosis	0.000575	0.00203	CcSEcCtD
Podofilox—Dizziness—Pamidronate—osteoporosis	0.000574	0.00202	CcSEcCtD
Podofilox—Headache—Risedronate—osteoporosis	0.000572	0.00202	CcSEcCtD
Podofilox—Pruritus—Zoledronate—osteoporosis	0.000561	0.00198	CcSEcCtD
Podofilox—Insomnia—Estradiol—osteoporosis	0.000553	0.00195	CcSEcCtD
Podofilox—Vomiting—Pamidronate—osteoporosis	0.000552	0.00195	CcSEcCtD
Podofilox—Paraesthesia—Estradiol—osteoporosis	0.000549	0.00193	CcSEcCtD
Podofilox—Rash—Pamidronate—osteoporosis	0.000547	0.00193	CcSEcCtD
Podofilox—Dermatitis—Pamidronate—osteoporosis	0.000547	0.00193	CcSEcCtD
Podofilox—Headache—Pamidronate—osteoporosis	0.000544	0.00192	CcSEcCtD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000542	0.00234	CbGpPWpGaD
Podofilox—Pruritus—Conjugated Estrogens—osteoporosis	0.00054	0.0019	CcSEcCtD
Podofilox—TUBA4A—Metabolism of proteins—RPL24—osteoporosis	0.000534	0.00231	CbGpPWpGaD
Podofilox—Dizziness—Zoledronate—osteoporosis	0.000524	0.00185	CcSEcCtD
Podofilox—Pain—Estradiol—osteoporosis	0.000522	0.00184	CcSEcCtD
Podofilox—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	0.000506	0.00219	CbGpPWpGaD
Podofilox—Dizziness—Conjugated Estrogens—osteoporosis	0.000505	0.00178	CcSEcCtD
Podofilox—Vomiting—Zoledronate—osteoporosis	0.000504	0.00178	CcSEcCtD
Podofilox—Rash—Zoledronate—osteoporosis	0.0005	0.00176	CcSEcCtD
Podofilox—Dermatitis—Zoledronate—osteoporosis	0.000499	0.00176	CcSEcCtD
Podofilox—Headache—Zoledronate—osteoporosis	0.000497	0.00175	CcSEcCtD
Podofilox—NR3C1—Adipogenesis—WNT1—osteoporosis	0.000496	0.00214	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—RAP1A—osteoporosis	0.000492	0.00213	CbGpPWpGaD
Podofilox—Vomiting—Conjugated Estrogens—osteoporosis	0.000485	0.00171	CcSEcCtD
Podofilox—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	0.000485	0.0021	CbGpPWpGaD
Podofilox—TUBA4A—Platelet degranulation—TGFB1—osteoporosis	0.000482	0.00208	CbGpPWpGaD
Podofilox—Rash—Conjugated Estrogens—osteoporosis	0.000481	0.0017	CcSEcCtD
Podofilox—Dermatitis—Conjugated Estrogens—osteoporosis	0.000481	0.0017	CcSEcCtD
Podofilox—Headache—Conjugated Estrogens—osteoporosis	0.000478	0.00169	CcSEcCtD
Podofilox—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	0.000472	0.00204	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—TLN1—osteoporosis	0.000469	0.00203	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	0.000461	0.00199	CbGpPWpGaD
Podofilox—TUBA4A—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	0.000459	0.00198	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.000454	0.00196	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—REN—osteoporosis	0.000451	0.00195	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—BMP2—osteoporosis	0.000448	0.00194	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—FGA—osteoporosis	0.000446	0.00193	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	0.000439	0.0019	CbGpPWpGaD
Podofilox—Pruritus—Estradiol—osteoporosis	0.000432	0.00152	CcSEcCtD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000414	0.00179	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000414	0.00179	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—FGB—osteoporosis	0.000406	0.00175	CbGpPWpGaD
Podofilox—Dizziness—Estradiol—osteoporosis	0.000404	0.00142	CcSEcCtD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	0.000402	0.00174	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	0.000397	0.00171	CbGpPWpGaD
Podofilox—Vomiting—Estradiol—osteoporosis	0.000388	0.00137	CcSEcCtD
Podofilox—Rash—Estradiol—osteoporosis	0.000385	0.00136	CcSEcCtD
Podofilox—Dermatitis—Estradiol—osteoporosis	0.000385	0.00136	CcSEcCtD
Podofilox—Headache—Estradiol—osteoporosis	0.000383	0.00135	CcSEcCtD
Podofilox—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	0.000379	0.00164	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	0.000377	0.00163	CbGpPWpGaD
Podofilox—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	0.000372	0.00161	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—PSMA5—osteoporosis	0.00037	0.0016	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—PSMA2—osteoporosis	0.00037	0.0016	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000357	0.00154	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000352	0.00152	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000352	0.00152	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000351	0.00152	CbGpPWpGaD
Podofilox—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000347	0.0015	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	0.000335	0.00145	CbGpPWpGaD
Podofilox—CYP2C19—Arachidonic acid metabolism—GPX1—osteoporosis	0.000331	0.00143	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	0.000327	0.00141	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000326	0.00141	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PSMA2—osteoporosis	0.000314	0.00136	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—PSMA5—osteoporosis	0.000314	0.00136	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	0.000299	0.00129	CbGpPWpGaD
Podofilox—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	0.000291	0.00126	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	0.000288	0.00124	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000285	0.00123	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	0.000284	0.00123	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—ACE—osteoporosis	0.000282	0.00122	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—LEP—osteoporosis	0.000277	0.0012	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000275	0.00119	CbGpPWpGaD
Podofilox—TOP2A—Retinoblastoma (RB) in Cancer—MYC—osteoporosis	0.000269	0.00116	CbGpPWpGaD
Podofilox—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	0.000261	0.00113	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PSMA2—osteoporosis	0.000246	0.00106	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—PSMA5—osteoporosis	0.000246	0.00106	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IRS2—osteoporosis	0.000246	0.00106	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—LEP—osteoporosis	0.00024	0.00104	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000238	0.00103	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PSMA2—osteoporosis	0.00022	0.000951	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—PSMA5—osteoporosis	0.00022	0.000951	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IRS1—osteoporosis	0.000214	0.000927	CbGpPWpGaD
Podofilox—TUBA4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000214	0.000924	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	0.000211	0.000913	CbGpPWpGaD
Podofilox—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000211	0.000912	CbGpPWpGaD
Podofilox—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	0.000208	0.000901	CbGpPWpGaD
Podofilox—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	0.0002	0.000865	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IGF1—osteoporosis	0.000199	0.000859	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	0.000196	0.000847	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	0.000195	0.000845	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000192	0.000832	CbGpPWpGaD
Podofilox—TOP2A—Mitotic G1-G1/S phases—MYC—osteoporosis	0.000189	0.000817	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—IGF1—osteoporosis	0.000184	0.000794	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000182	0.000789	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—LEP—osteoporosis	0.000175	0.000756	CbGpPWpGaD
Podofilox—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	0.000174	0.000754	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	0.000174	0.000753	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—U2AF1—osteoporosis	0.000174	0.000751	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	0.000173	0.000748	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000171	0.00074	CbGpPWpGaD
Podofilox—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000171	0.000739	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	0.000171	0.000738	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	0.000151	0.000654	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—POMC—osteoporosis	0.00015	0.00065	CbGpPWpGaD
Podofilox—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	0.000149	0.000645	CbGpPWpGaD
Podofilox—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	0.000147	0.000637	CbGpPWpGaD
Podofilox—TUBA4A—Metabolism of proteins—IGF1—osteoporosis	0.000145	0.000625	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000143	0.000619	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000143	0.000617	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000142	0.000613	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000138	0.000598	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	0.000138	0.000597	CbGpPWpGaD
Podofilox—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000133	0.000577	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	0.000132	0.000573	CbGpPWpGaD
Podofilox—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	0.00013	0.000561	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—RPL24—osteoporosis	0.000129	0.000558	CbGpPWpGaD
Podofilox—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	0.000127	0.000549	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TGFB1—osteoporosis	0.000119	0.000515	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle, Mitotic—MYC—osteoporosis	0.000117	0.000504	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—TNF—osteoporosis	0.000111	0.000481	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000111	0.000478	CbGpPWpGaD
Podofilox—TUBA4A—Hemostasis—TGFB1—osteoporosis	0.00011	0.000476	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	0.00011	0.000474	CbGpPWpGaD
Podofilox—TUBA4A—Cell Cycle—MYC—osteoporosis	0.000104	0.000451	CbGpPWpGaD
Podofilox—TOP2A—Circadian rythm related genes—IL6—osteoporosis	0.000103	0.000447	CbGpPWpGaD
Podofilox—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000103	0.000445	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle, Mitotic—MYC—osteoporosis	9.91e-05	0.000428	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	9.61e-05	0.000416	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.4e-05	0.000406	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	9.09e-05	0.000393	CbGpPWpGaD
Podofilox—CYP2C19—Biological oxidations—POMC—osteoporosis	9.09e-05	0.000393	CbGpPWpGaD
Podofilox—NR3C1—Adipogenesis—IL6—osteoporosis	8.97e-05	0.000388	CbGpPWpGaD
Podofilox—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	8.97e-05	0.000388	CbGpPWpGaD
Podofilox—TUBB—Cell Cycle—MYC—osteoporosis	8.86e-05	0.000383	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PKM—osteoporosis	8.57e-05	0.00037	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—FDPS—osteoporosis	8.57e-05	0.00037	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	8.38e-05	0.000362	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PGLS—osteoporosis	8.12e-05	0.000351	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPD2—osteoporosis	8.12e-05	0.000351	CbGpPWpGaD
Podofilox—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	7.76e-05	0.000335	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMA5—osteoporosis	7.45e-05	0.000322	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—PSMA2—osteoporosis	7.45e-05	0.000322	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ATIC—osteoporosis	7.43e-05	0.000321	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PNP—osteoporosis	7.43e-05	0.000321	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle, Mitotic—MYC—osteoporosis	6.93e-05	0.0003	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR2—osteoporosis	6.65e-05	0.000288	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CA2—osteoporosis	6.32e-05	0.000273	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—OXCT1—osteoporosis	6.32e-05	0.000273	CbGpPWpGaD
Podofilox—TOP2A—Cell Cycle—MYC—osteoporosis	6.2e-05	0.000268	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MGLL—osteoporosis	6.16e-05	0.000266	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.81e-05	0.000251	CbGpPWpGaD
Podofilox—CYP3A4—Biological oxidations—POMC—osteoporosis	5.46e-05	0.000236	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—VDR—osteoporosis	5.28e-05	0.000228	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—IDH2—osteoporosis	5.24e-05	0.000226	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PKM—osteoporosis	5.15e-05	0.000223	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—FDPS—osteoporosis	5.15e-05	0.000223	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP27A1—osteoporosis	4.92e-05	0.000213	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPD2—osteoporosis	4.89e-05	0.000211	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PGLS—osteoporosis	4.89e-05	0.000211	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ACP5—osteoporosis	4.79e-05	0.000207	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.73e-05	0.000204	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PNP—osteoporosis	4.47e-05	0.000193	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ATIC—osteoporosis	4.47e-05	0.000193	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—TPI1—osteoporosis	4.45e-05	0.000192	CbGpPWpGaD
Podofilox—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	4.36e-05	0.000188	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—P4HB—osteoporosis	4.19e-05	0.000181	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GAPDH—osteoporosis	4.11e-05	0.000178	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—ESR1—osteoporosis	4.04e-05	0.000174	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—RAP1A—osteoporosis	4e-05	0.000173	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—OXCT1—osteoporosis	3.8e-05	0.000164	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CA2—osteoporosis	3.8e-05	0.000164	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MGLL—osteoporosis	3.7e-05	0.00016	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.49e-05	0.000151	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ENO1—osteoporosis	3.23e-05	0.00014	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMA5—osteoporosis	3.19e-05	0.000138	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—PSMA2—osteoporosis	3.19e-05	0.000138	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—IDH2—osteoporosis	3.15e-05	0.000136	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP27A1—osteoporosis	2.96e-05	0.000128	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ACP5—osteoporosis	2.88e-05	0.000124	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—TPI1—osteoporosis	2.68e-05	0.000116	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—CYP19A1—osteoporosis	2.59e-05	0.000112	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—P4HB—osteoporosis	2.52e-05	0.000109	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GAPDH—osteoporosis	2.47e-05	0.000107	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—RAP1A—osteoporosis	2.41e-05	0.000104	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—ADCY5—osteoporosis	2.11e-05	9.13e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—GPX1—osteoporosis	2.11e-05	9.1e-05	CbGpPWpGaD
Podofilox—NR3C1—Gene Expression—MYC—osteoporosis	2.1e-05	9.07e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ENO1—osteoporosis	1.95e-05	8.41e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—MTHFR—osteoporosis	1.94e-05	8.4e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMA2—osteoporosis	1.92e-05	8.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—PSMA5—osteoporosis	1.92e-05	8.28e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.55e-05	6.72e-05	CbGpPWpGaD
Podofilox—CYP2C19—Metabolism—POMC—osteoporosis	1.55e-05	6.72e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—ADCY5—osteoporosis	1.27e-05	5.49e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—GPX1—osteoporosis	1.27e-05	5.47e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—MTHFR—osteoporosis	1.17e-05	5.05e-05	CbGpPWpGaD
Podofilox—CYP3A4—Metabolism—POMC—osteoporosis	9.34e-06	4.04e-05	CbGpPWpGaD
